IDH1 and central nervous system cancer: That is, R132H mutation, which disrupts normal function of isocitrate dehydrogenase IDH1, negatively affects the growth of glioma progenitor cells, but genetically induced expression of human GLUD2 but not GLUD1 rescues the cells.